Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) have been given an average recommendation of “Moderate Buy” by the eleven research firms that are currently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $100.30.

A number of research analysts have recently issued reports on the stock. Barrington Research set a $114.00 price target on shares of Merit Medical Systems in a research report on Friday, July 31st. Weiss Ratings raised shares of Merit Medical Systems from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, August 3rd. Piper Sandler increased their price objective on shares of Merit Medical Systems from $96.00 to $106.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. Needham & Company LLC upped their target price on Merit Medical Systems from $90.00 to $101.00 and gave the company a “buy” rating in a report on Friday, July 31st. Finally, JPMorgan Chase & Co. raised their price target on Merit Medical Systems from $77.00 to $95.00 and gave the stock an “overweight” rating in a report on Friday, July 31st.

Institutional Investors Weigh In On Merit Medical Systems

Hedge funds have recently added to or reduced their stakes in the stock. State Street Corp grew its position in shares of Merit Medical Systems by 1.5% during the fourth quarter. State Street Corp now owns 2,231,048 shares of the medical instruments supplier’s stock worth $196,645,000 after acquiring an additional 32,459 shares during the last quarter. Conestoga Capital Advisors LLC increased its holdings in shares of Merit Medical Systems by 3.9% in the 1st quarter. Conestoga Capital Advisors LLC now owns 2,167,513 shares of the medical instruments supplier’s stock worth $149,407,000 after acquiring an additional 81,030 shares during the period. Fuller & Thaler Asset Management Inc. lifted its position in Merit Medical Systems by 12.7% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 2,077,796 shares of the medical instruments supplier’s stock valued at $183,137,000 after purchasing an additional 234,682 shares during the last quarter. Wellington Management Group LLP lifted its position in Merit Medical Systems by 7.0% in the 4th quarter. Wellington Management Group LLP now owns 1,327,013 shares of the medical instruments supplier’s stock valued at $116,963,000 after purchasing an additional 86,504 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in Merit Medical Systems by 1.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,237,298 shares of the medical instruments supplier’s stock valued at $85,287,000 after purchasing an additional 12,285 shares during the period. 99.66% of the stock is currently owned by institutional investors.

Merit Medical Systems Price Performance

Shares of MMSI opened at $91.20 on Friday. Merit Medical Systems has a 52 week low of $59.74 and a 52 week high of $94.75. The company has a current ratio of 4.20, a quick ratio of 2.79 and a debt-to-equity ratio of 0.44. The firm has a market cap of $5.45 billion, a price-to-earnings ratio of 37.69, a PEG ratio of 2.29 and a beta of 0.49. The stock has a 50 day moving average of $73.98 and a 200-day moving average of $72.06.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.23. The business had revenue of $418.84 million for the quarter, compared to analyst estimates of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The business’s revenue was up 9.5% compared to the same quarter last year. During the same period in the prior year, the company posted $1.01 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, analysts forecast that Merit Medical Systems will post 3.81 EPS for the current year.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.